Urinary Frequency
11
4
4
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
36%
4 trials in Phase 3/4
60%
3 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (11)
A Single-Arm Exploratory Study of NatureU Pelvic Health Pumpkin Seed in Women With Urinary Frequency and Leakage Symptoms
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
Intradetrusor Botulinum Toxin A for OAB Via 1 Versus 10 Injections: A Randomized Clinical Trial
BTL Emsella Chair Versus Sham for the Treatment of Overactive Bladder
APPROVE Trial: Evaluating a Prescription Digital Therapeutic for Treatment of OAB in Women
Micturition Desire-Relaxation Training Device for Lower Urinary Tract Dysfunction in Children
FREEOAB Study for Overactive Bladder
Optimal Intravesical Lidocaine Volume for Pain Relief During Office Intra-detrusor Onabotulinum Toxin a Injections
Efficacy and Safety of Gabapentin in Treating Overactive Bladder
Study of Topically Administered Oxybutynin Gel in Patients With Urge Incontinence
Evaluation of Solifenacin in the Treatment of OAB Symptoms in Patients Who Have Successfully Undergone GreenLight Photoselective Vaporization of the Prostate (PVP)